FILIP JANKU to Human Umbilical Vein Endothelial Cells
This is a "connection" page, showing publications FILIP JANKU has written about Human Umbilical Vein Endothelial Cells.
Connection Strength
0.041
-
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants. Cancer Cell. 2019 05 13; 35(5):738-751.e9.
Score: 0.041
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.